The design of single-factor experiment is commonly used to compare multiple groups in non-clinical studies, where groups generally have small size and different variances. The classical F test tends to inflate type I error rate in this scenario. Many alternative tests have been proposed in the literature to manage heteroscedasticity. Several papers compared these alternative tests, among which is heterogeneous-variance mixed-effects model. The mixed-effects model approach has at least 2 advantages over other tests: (1) allowing different group variance structures (e.g. homogeneous-variance or heterogeneous-variance); and (2) the capacity to do model diagnosis via residual analysis. In this article, we conducted comprehensive simulation experiments to evaluate both type I error rate and power of the 13 tests investigated in Pham et al. (Citation2020) spanning ANOVA-based tests, structured means modeling (SMM), and mixed-effects models—under diverse conditions, including (un)equal variances, (non-)normal distributions, and (un)balanced designs. Two additional mixed-effects models (homogeneous-variance mixed-effects model and adaptive mixed-effects model) were introduced and assessed alongside the 13 tests. We also considered the Kenward-Roger approximation of degrees of freedom for the 3 mixed-effects models, which generally offers more reliable type I error rate than the Satterthwaite approximation. Results suggested that no single method consistently outperforms across all scenarios.
No takes yet. Share an insight, caveat, or question.
Gao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: